MIFLONIDE

This brand name is authorized in Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Israel, Poland, Tunisia

Active ingredients

The drug MIFLONIDE contains one active pharmaceutical ingredient (API):

1 Budesonide UNII Q3OKS62Q6X - BUDESONIDE

Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers. Read about Budesonide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03BA02	Budesonide	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 526510601117416, 526510602113414, 526520110096407
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 09290063, 09290152, 11862035, 11862041, 11862058, 11862064, 14341549, 14372343, 14398911, 15584633
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.088-04-03
Country: EE	Ravimiamet	Identifier(s): 1124390, 1124413
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 63197, 63198
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4525, 4526
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100106959, 100106965
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 10283141, 10283142